Finally, although RA-specific changes in barrier markers were not detected, an upward trend in IL17a and a significant increase in IL4 and IL1ß was observed in DSS-treated N1RA/RA; N2RA/RA relative to WT (Fig 2H), consistent with enhanced inflammatory responses driving colitis in these animals. The gene discussed is IL17A; the disease is colitis.